Guidelines for migraine made simple

Treatment  ·  May 2, 2026

From the Guidelines

Evidence-Based Diagnosis and Management

Ten-Step Approach to Migraine Care

The most comprehensive approach to migraine management follows a structured ten-step process [1]:

Preventive Treatment Options

For episodic migraine (1-14 headache days per month), several evidence-based preventive medications are available [5]:

Combination Therapy Approaches

For treatment-resistant cases, combining therapies shows promise [2]:

Established Clinical Knowledge

Based on standard clinical practice, migraine management should include:

Acute Treatment Principles

Lifestyle Management

Trigger Identification

Additional Considerations

Sleep and Migraine Connection

Sleep symptoms are integral to migraine management [3]:

Nutritional Factors

Diet and gut health play important roles [4]:

Limitations

The available sources primarily focus on preventive treatments for episodic migraine and don't extensively cover:

Key Takeaway: Migraine management requires a comprehensive, patient-centered approach combining evidence-based pharmacological treatments with lifestyle modifications and addressing comorbid conditions like sleep disorders and dietary factors.

Sources

[3]
Sleep Symptoms in Migraine. — Curr Neurol Neurosci Rep, 2024

Frequently Asked Questions

What are the first-line preventive medications for episodic migraine?

First-line preventive medications include beta-blockers (metoprolol, propranolol), antiseizure medications (valproate, topiramate), blood pressure medications (lisinopril, candesartan, telmisartan), and antidepressants (amitriptyline, fluoxetine, venlafaxine). CGRP-targeted therapies such as monoclonal antibodies and gepants are also evidence-based options for migraine prevention.

What is the ten-step approach to migraine management?

The ten-step approach includes patient-centered care with education, proper diagnosis using established clinical criteria, individualized treatment plans for different populations, treatment response evaluation and failure management, and long-term follow-up with comorbidity management. This structured process ensures comprehensive and evidence-based migraine care.

What combination therapy approaches work for treatment-resistant migraine?

For treatment-resistant migraines, dual CGRP inhibition using both monoclonal antibodies and gepants, OnabotulinumtoxinA combined with CGRP treatments for synergistic effects, and oral conventional prophylactics combined with newer treatments have shown promise. These combination approaches can be considered when single-agent therapy is insufficient.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Mentor MD assumes no liability for clinical decisions based on this content.